J. Talks Et Al. , "The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration," SURVEY OF OPHTHALMOLOGY , vol.64, no.5, pp.707-719, 2019
Talks, J. Et Al. 2019. The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration. SURVEY OF OPHTHALMOLOGY , vol.64, no.5 , 707-719.
Talks, J., Daien, V., Finger, R. P., Eldem, B., Sakamoto, T., Cardillo, J. A., ... Mitchell, P.(2019). The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration. SURVEY OF OPHTHALMOLOGY , vol.64, no.5, 707-719.
Talks, James Et Al. "The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration," SURVEY OF OPHTHALMOLOGY , vol.64, no.5, 707-719, 2019
Talks, James Et Al. "The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration." SURVEY OF OPHTHALMOLOGY , vol.64, no.5, pp.707-719, 2019
Talks, J. Et Al. (2019) . "The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration." SURVEY OF OPHTHALMOLOGY , vol.64, no.5, pp.707-719.
@article{article, author={James Talks Et Al. }, title={The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration}, journal={SURVEY OF OPHTHALMOLOGY}, year=2019, pages={707-719} }